X-ray Fluorescence Protein Modification Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing post-translational modifications of proteins are labor-intensive and require expensive or hazardous chemical reagents, such as radioactive materials, generating waste and being inefficient in mimicking biological concentrations.

Innovation Solution

A method involving a solution of acceptor and donor chemicals, with a controller chemical, where the reaction is incubated and the products are measured using X-ray fluorescence, allowing for the separation and quantification of unreacted donor and acceptor products.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If radioactive materials are used in kinase assays, then measurement capability is achieved, but hazardous waste is generated and safety risks increase

Engineering Contradiction:
Improvemeasurement capabilityVSAvoidhazardous waste
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent replaces expensive, hazardous radioactive materials with inexpensive, non-radioactive alternatives. The assay uses standard chemical reagents that can be discarded after use without special handling requirements, eliminating the need for expensive radioactive waste disposal procedures while maintaining measurement capability through alternative detection methods

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent converts the previously harmful radioactive materials into beneficial non-radioactive chemical reagents. By using chemically reactive but non-hazardous substrates and detectors that measure chemical changes rather than radioactivity, the system transforms a harmful measurement approach into a safe one while preserving the ability to detect kinase activity

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Measurement precision

If micromolar concentrations of ATP are used in assays, then reaction detectability is improved, but physiological relevance is lost

Engineering Contradiction:
Improvereaction detectabilityVSAvoidphysiological relevance
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent changes the concentration parameter of ATP from micromolar to millimolar ranges, aligning assay conditions with physiological conditions. This parameter adjustment is compensated by optimizing other assay parameters such as detector sensitivity and reaction time to maintain detectability while achieving physiological relevance

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a dynamic assay system where millimolar ATP concentrations can be precisely controlled and adjusted to match physiological conditions. The system allows real-time monitoring of kinase activity under physiologically relevant conditions, enabling studies of enzyme kinetics that accurately reflect in vivo behavior

Inventive Principle:
Principle #15Dynamics

3Measurement precision

If substrate concentrations much higher than in vivo are used, then signal strength is increased, but biological accuracy is reduced

Engineering Contradiction:
Improvesignal strengthVSAvoidbiological accuracy
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent changes the substrate concentration parameter from supraphysiological to physiological ranges. By using highly sensitive detectors and optimizing reaction conditions, the system maintains adequate signal strength while using substrate concentrations that accurately reflect biological conditions, enabling meaningful interpretation of kinase activity in physiological contexts

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method simplifies the analysis of protein post-translational modifications by reducing the need for hazardous reagents and improving the accuracy of measurements, while minimizing waste and better mimicking in vivo conditions.

Implementation Method 1

The acceptor product or the donor chemical is then measured using X-ray fluorescence

Methodology Applied
Scientific EffectX-ray fluorescence: Fluorescence

Data Source

PatentUS11561188B2Method and apparatus for measuring protein post-translational modification
Publication Date: 2023.01.24 ICAGEN INC
  • US11561188B2 patent drawing
  • US11561188B2 patent drawing
  • US11561188B2 patent drawing

AI summary

The present invention includes a method for analyzing reactions. The method includes the steps of providing a solution of at least one acceptor chemical and at least one donor chemical. The donor chemical is capable of donating a chemical moiety to the acceptor chemical. The solution further includes at least one controller chemical that affects the reaction between the donor chemical and the acceptor chemical. The solution is then incubated so that a portion of the acceptor chemical reacts with the donor chemical to form an acceptor product. Unreacted donor chemical is separated from the acceptor product. The acceptor product or the donor chemical is then measured using X-ray fluorescence. Another aspect of the present invention includes a method for analyzing protein function. The method includes the steps of providing a solution of at least one acceptor chemical and at least one donor chemical. The donor chemical is capable of donating a chemical moiety to the acceptor chemical. The donor chemical includes a functional group selected from ester, anhydride, imide, acyl halide, and amide. The solution is then incubated so that a portion of the acceptor chemical reacts with the donor chemical to form an acceptor product. Unreacted donor chemical is separated from the acceptor product. The acceptor product or the donor chemical is then measured using X-ray fluorescence. Yet another aspect of the present invention includes a method for analyzing protein function. The method includes the steps of providing a solution of at least one acceptor chemical and at least one donor chemical. The solution is then incubated so that a portion of the acceptor chemical reacts with the donor chemical to form an acceptor product. Unreacted donor chemical is separated from the acceptor product. The acceptor product or the donor chemical is then measured using X-ray fluorescence. An additional analytical method is also used to measure either the acceptor product or the donor chemical.